Skip to main content
Elekta logo

Elekta — Investor Relations & Filings

Ticker · EKTA ISIN · SE0000163628 LEI · 54930044O54BK617EP80 ST Manufacturing
Open in API
Filings indexed 1,126 across all filing types
Latest filing 2026-05-28 Earnings Release
Country SE Sweden
Listing ST EKTA

About Elekta

https://www.elekta.com/

Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Earnings Release 2026
Earnings Release Classification · 90% confidence The document is a detailed financial press release (“bokslutskommuniké”) covering the fourth quarter and full year 2025/26 results, with actual P&L figures, margins, cash flow, tables of KPIs, management commentary, and a dividend proposal. It is not the formal statutory annual report (10-K) nor a regulatory announcement of filing; instead it is the company’s initial announcement of periodical financial results. Therefore it best fits the Earnings Release category. FY 2026
2026-05-28 Swedish
Earnings Release 2026
Earnings Release Classification · 85% confidence The document is a “Year-end report” presenting the company’s fourth‐quarter and full‐year financial results, with key metrics (sales, margins, EBIT, net income, cash flows), segment and regional breakdowns, management commentary, and an outlook. It reads like an earnings press release summarizing results rather than a full statutory annual report (10-K). It is the initial announcement of periodical financial results. Therefore, it should be classified as an Earnings Release (ER). FY 2026
2026-05-28 English
Major Shareholding Notification 2026
Major Shareholding Notification Classification · 100% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding by The Goldman Sachs Group, Inc. in Elekta AB, specifically reporting a sale of shares and crossing of ownership thresholds. This falls under the category of Major Shareholding Notification (MRQ).
2026-03-12 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Elekta Delårsrapport' (Interim Report) for the third quarter (November–January 2025/26). It contains comprehensive financial statements, including income statements, balance sheet summaries, and detailed management analysis of financial performance, regional results, and product segments. It is clearly a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q3 2025
2026-03-05 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Elekta Interim report' and covers the third quarter (November–January 2025/26). It contains detailed financial statements, including net sales, EBIT, net income, cash flow, and regional performance tables. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q3 2025
2026-03-05 English
Elekta får FDA 510(k)-godkännande för linjäracceleratorn Elekta Evo
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Elekta has received FDA 510(k) clearance for its 'Elekta Evo' medical device. It describes the product's features, provides quotes from company executives and medical professionals, and includes contact information. This is a standard corporate announcement regarding product regulatory approval and business development, which does not fit into specific financial reporting categories like earnings or dividends. Therefore, it is classified as a general regulatory filing/announcement.
2026-01-16 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.